Cargando…
Physcion increases the sensitivity of hepatocellular carcinoma to sorafenib through miRNA-370/PIM1 axis-regulated glycolysis
BACKGROUND: Resistance to sorafenib has become a challenge in clinical treatment of hepatocellular carcinoma (HCC). Physcion is a common bioactive anthraquinone that has potential as an anticancer agent. AIM: To study the effect of physcion on sensitizing HCC cells to sorafenib. METHODS: Sorafenib-r...
Autores principales: | Pan, Xiao-Ping, Jiya, Bu-Ren, Wang, Feng, Lan, Zhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473927/ https://www.ncbi.nlm.nih.gov/pubmed/37663938 http://dx.doi.org/10.4251/wjgo.v15.i8.1400 |
Ejemplares similares
-
Circular RNA CircITGA7 Promotes Tumorigenesis of Osteosarcoma via miR-370/PIM1 Axis
por: Fang, Chuanwu, et al.
Publicado: (2020) -
Retracted: Circular RNA CircITGA7 Promotes Tumorigenesis of Osteosarcoma via miR-370/PIM1 Axis
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Development of an Aerobic Glycolysis Index for Predicting the Sorafenib Sensitivity and Prognosis of Hepatocellular Carcinoma
por: Pan, Yu, et al.
Publicado: (2021) -
PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma
por: Leung, Carmen Oi-ning, et al.
Publicado: (2015) -
The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma
por: Zhang, Zhongqiang, et al.
Publicado: (2020)